Bavarian Nordic (BVNRY) Stock Price, Quote, News & History

Bavarian Nordic AS (BVNRY) Stock Price, Quote, News & History

BVNRYOTCPK

Trade with Public

$9.11

Last update: Mar 12, 2:39 PM

Key Statistics

Open

Volume / Avg.

0 / 1.77K

Day Range

- - -

52 Wk Range

6.60 - 13.00

Market Cap

$2.12B

P/E Ratio

5.76

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Bavarian Nordic A/S News

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.

Vandana Singh

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.

Vandana Singh

Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic

The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

3.13B

Investing Cash Flow (TTM)

-1.90B

Financing Cash Flow (TTM)

-120.96M

Free Cash Flow (TTM)

1.28B

Capital Expenditure (TTM)

-1.85B

Net Change in Cash (TTM)

1.11B

Valuation Metrics

Enterprise Value

$1.69B

PE Ratio (TTM)

5.76

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.05

PB Ratio (TTM)

1.04

Earnings Yield % (TTM)

17.36%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

3.41

Price / EBITDA (TTM)

4.41

Price / Free Cash Flow (TTM)

11.02

Book Value / Share

$8.74

Company Debt

Total Debt

$13.56M

LT Debt

$11.42M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$2.06M

Total Cash

$2.09B

Debt to Equity

0.01

Issuance of Debt (TTM)

-$2.06M

Repayment of Debt (TTM)

-$2.06M

Key Statistics

Open

Volume / Avg.

0 / 1.77K

Day Range

- - -

52 Wk Range

6.60 - 13.00

Market Cap

$2.12B

P/E Ratio

5.76

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedne...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Bavarian Nordic (BVNRY) stock?

You can purchase shares of Bavarian Nordic (OTCPK:BVNRY) through any online brokerage.

View our list of the best stock brokerages

Who are Bavarian Nordic (BVNRY) competitors?

There are no as such competitors for Bavarian Nordic.

What is the forecast, or price target, for Bavarian Nordic (BVNRY) stock?

There is no analysis for Bavarian Nordic to provide a consensus price target.

What is the current price for Bavarian Nordic (BVNRY)?

The stock price for Bavarian Nordic (OTCPK: BVNRY) is $9.106 last updated March 12, 2026 at 2:39 PM EDT.

Does Bavarian Nordic (BVNRY) pay a dividend?

There are no upcoming dividends for Bavarian Nordic.

When is Bavarian Nordic (OTCPK:BVNRY) reporting earnings?

Bavarian Nordic does not have any upcoming earnings scheduled.

Is Bavarian Nordic (BVNRY) going to split?

There is no upcoming split for Bavarian Nordic.

What sector and industry does Bavarian Nordic (BVNRY) operate in?

Bavarian Nordic is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

0 / 1.77K

Day Range

- - -

52 Wk Range

6.60 - 13.00

Market Cap

$2.12B

P/E Ratio

5.76

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Bavarian Nordic A/S News

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.

Vandana Singh

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.

Vandana Singh

Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic

The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval.

Vandana Singh